m7G-related gene signatures determine prognosis in triple-negative breast cancer

Yunxiang Li1, Xin Lan2, Jianqiao Dong2

  • 1Department of Breast Surgery, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.

Scientific Reports
|October 28, 2025
PubMed

Insights

This study identifies m7G modifications as key in triple-negative breast cancer (TNBC) prognosis. A novel risk model stratifies patients, guiding personalized therapies and improving survival predictions for this challenging cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Triple-negative breast cancer (TNBC) presents a significant clinical challenge due to a lack of targeted therapies.
  • Understanding the molecular drivers and prognostic factors in TNBC is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the role of m7G modifications in TNBC.
  • To develop a prognostic risk model based on m7G-related genes.
  • To explore the relationship between m7G modifications, the tumor immune microenvironment, and patient survival.

Main Methods:

  • Integrated analysis of m7G-related genes in TNBC.
  • Development of a risk stratification model.
  • Analysis of immune cell infiltration and genomic mutations.
  • Chemosensitivity profiling and nomogram construction.

Main Results:

  • A risk model based on differentially expressed m7G-related genes effectively stratified TNBC patients into low- and high-risk groups with distinct survival outcomes.
  • Significant differences in immune cell infiltration were observed between risk groups.
  • Distinct genomic mutation patterns, including TP53 and PIK3CA, were associated with risk groups.
  • The risk score showed potential for predicting chemosensitivity and was incorporated into a nomogram for survival prediction.

Conclusions:

  • m7G modifications are significantly associated with TNBC prognosis and the tumor immune microenvironment.
  • The developed m7G-related risk score serves as a valuable tool for patient stratification and personalized treatment strategies in TNBC.
  • A predictive nomogram incorporating the risk score offers improved accuracy for long-term survival probability estimation in TNBC patients.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K